Multiple Myeloma Clinical Trial

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Summary

The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substance that looks like the study supplements) affect butyrate levels in participants' stool.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Confirmed diagnosis of MGUS or SMM
If non light chain MGUS/SMM then M spike must be either ≥ 0.2 g/dL or BM PC ≥10% (both not required)
If light chain MGUS/SMM then involved must be ≥10 mg/dL or BM PC ≥10% (both not required)
If IgA MGUS/SMM then an IgA level >350 mg/dL and an abnormal immunofixation is required (M spike criteria not required).
If IgD MGUS/SMM then an IgD level >50 mg/dL and an abnormal immunofixation is required (M spike criteria not required).
Age ≥18 years
Willingness to comply with all study-related procedures
ECOG performance status of 0-3
Interested in learning to cook plant based recipes

Exclusion Criteria:

Patients that already follow a whole foods plant based diet (ovo-lacto-vegetarian or processed junk food vegan diets are not excluded)
Legume allergy
Severe allergies such as anaphylactic shock to nuts (specifically cashews). Peanuts are not included in the meals.
Concurrent participation in weight loss/dietary/exercise programs
Mental impairment leading to inability to cooperate
Enrollment onto any other therapeutic investigational study
Concurrent pregnancy
Positive HBV, HCV or HIV PCR test will need to be treated first and once undetectable viral load patients may enroll
≥ Grade 2 electrolyte abnormalities as defined by CTCAEv5.0 (need to be resolved before enrolling on study)
If in the opinion of the investigator there maybe any concerns regarding the ability of the patient to complete the study safely or any contraindications
Heavy drinker (defined as >2 drinks per day or >14 drinks per week)
Current self-reported illicit drug use (eg heroin, cocaine not marijuana)

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

150

Study ID:

NCT05640843

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info
Urvi Shah, MBBS
Contact
646-608-3713
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown New Jersey, 07748, United States More Info
Urvi Shah, MBBS
Contact
646-608-3713
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale New Jersey, 07645, United States More Info
Urvi Shah, MBBS
Contact
646-608-3713
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)
Commack New York, 11725, United States More Info
Urvi Shah, MBBS
Contact
646-608-3713
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison New York, 10604, United States More Info
Urvi Shah, MBBS
Contact
646-608-3713
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York New York, 10065, United States More Info
Urvi Shah, MBBS
Contact
646-608-3713
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale New York, 11553, United States More Info
Urvi Shah, MBBS
Contact
646-608-3713

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

150

Study ID:

NCT05640843

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.